SCIREQ & 3RsC are hosting a virtual webinar on Maximizing Drug Development Efficiency Using Predictive in vitro and ex vivo Models.
Stay tuned for more talk-specific information!
Speaker: Dr. Katharina Schwarz
Dr. Katharina Schwarz (f) leads the department “Aerosol Technology and Aerosol Biophysics” at the Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM) in Hannover, Germany.
She is an expert at the interface between aerosol/inhalation research, respiratory pharmacokinetics, toxicology/physiology, and inhalation exposure science with a special focus on particle lung dosimetry and biophysical particle-lung interactions. In her institutional role she is responsible for the aerosol aerosol/inhalation and dosimetry-related/QIVIVE-related aspects in drug development programs as well as toxicological and inhalation exposure studies including GLP/GCP-compliance. Customers are major pharmaceutical, chemical and cosmetic companies from Europe and US as well regulatory authorities.